Activist 13D/13G Filings - UBS Oncology Impact Fund L.P.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2023-02-09
4:04 pm
Sale
13GMEI Pharma, Inc.
MEIP
UBS Oncology Impact Fund L.P.0
0%
-10,137,859decrease
(Position Closed)
View
2021-02-16
08:32 am
Purchase
13GMEI Pharma, Inc.
MEIP
UBS Oncology Impact Fund L.P.10,137,859
9%
3,887,859increase
(+62.21%)
View
2021-01-19
4:33 pm
Purchase
13DCullinan Oncology, Inc.
CGEM
UBS Oncology Impact Fund L.P.8,546,093
19.6%
8,546,093increase
(New Position)
View
2020-04-08
1:54 pm
Sale
13GSpring Bank Pharmaceuticals Inc.
SBPH
UBS Oncology Impact Fund L.P.603,070
3.5%
-833,839decrease
(-58.03%)
View
2020-02-05
2:13 pm
Sale
13GSUNESIS PHARMACEUTICALS INC
SNSS
UBS Oncology Impact Fund L.P.2,809,912
2.5%
-2,146,588decrease
(-43.31%)
View
2020-02-05
2:11 pm
Purchase
13GMEI Pharma, Inc.
MEIP
UBS Oncology Impact Fund L.P.6,250,000
5.9%
6,250,000increase
(New Position)
View